Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, 4-way Crossover Study to Evaluate the Food Effect and the Absorption Profile of Investigational Product of "Ibuprofen Controlled-Release Tablets 600 mg" in Comparison to the Reference Standard Ibuprofen Tablets 200 mg in Normal Healthy Volunteers

Trial Profile

A Randomized, 4-way Crossover Study to Evaluate the Food Effect and the Absorption Profile of Investigational Product of "Ibuprofen Controlled-Release Tablets 600 mg" in Comparison to the Reference Standard Ibuprofen Tablets 200 mg in Normal Healthy Volunteers

Suspended
Phase of Trial: Phase I

Latest Information Update: 28 Aug 2018

At a glance

  • Drugs Ibuprofen (Primary) ; Ibuprofen
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors Overseas Pharmaceuticals
  • Most Recent Events

    • 20 Aug 2018 Planned End Date changed from 24 Jun 2018 to 31 Dec 2020.
    • 20 Aug 2018 Planned primary completion date changed from 13 Apr 2018 to 30 Jun 2020.
    • 07 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top